Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Sanidad de Castilla y León | OTHER |
| Instituto de Neurociencia de Castillas y Leon | OTHER |
Not provided
Not provided
Not provided
Not provided
Introduction: One of the consequences of aging is the decrease in physical performance which can affect the quality of life of older people. Although physical exercise is beneficial in improving this problem, older women do not seem to benefit as much as men. In this sense, the use of ergonomic aids by women could compensate for these issues. Thus, green tea has shown beneficial effects on physical performance in athletes through, among others, improving blood flow and vasodilation, mitochondrial respiration, calcium management, glucose and amino acid uptake, lipid oxidation, modulation of muscle damage, antioxidant effect, and anabolic and catabolic hormones, activation of the hypothalamic-pituitary-adrenal axis, etc. Therefore, the deterioration of physical performance and quality of life of green tea.
Objective: To analyze the effect of supplementation with 1 g/day green tea extract (500 mg of polyphenols) for 10 weeks on quality of life values, physical performance (grip strength, walking speed, and resistance), and health biomarkers (biochemical, hematological, and hormonal) in women over 60 years of age who follow a physical training program.
Methods: A total of 20 female volunteers between 60 and 73 years old (age: 65.9±4.58 years, BMI: 25.09±3.24 and body fat percentage: 32.54±6.39) who followed a physical activity adapted to their age and abilities are the members of this study. The volunteers were divided into two groups: placebo (CG; n = 10) and supplemented with 1 g/day of green tea (GI; n = 10). Different physical tests were performed (grip strength, walking speed and resistance) and the quality of life questionnaire (WHOQOL-BREF) was passed and health biomarkers (biochemical, hematological, and hormonal) were analyzed at the beginning (T1) and at the end of the 10 weeks of intervention (T2).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Green tea supplementation group | Experimental | 2 capsules for 10 consecutive weeks, distributed in a single daily oral intake with the main meal |
|
| Placebo supplementation group | Placebo Comparator | 2 capsules for 10 consecutive weeks, distributed in a single daily oral intake with the main meal |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Green tea (Camellia sinensis) 1000 mg as extract | Dietary Supplement | Two capsules per day; Each capsule includes Green Tea Leaf (Camellia sinensis) 5000 mg composed of 500 mg of green tea extract and 250 mg of polyphenols (epicatechin (EC), epigallocatechin (EGC), epicatechin gallato (ECG), and epigallocatechin gallato (EGCG)) |
| Measure | Description | Time Frame |
|---|---|---|
| Creatine kinase (CK) | CK is an enzyme expressed by various tissues and cell types; markers of muscle damage | first day of study and after 30 days of supplementation (end of study) |
| Lactate dehydrogenase (LDH) | LDH is a catalytic enzyme found in many tissues of the body;markers of muscle damage | first day of study and after 30 days of supplementation (end of study) |
| Measure | Description | Time Frame |
|---|---|---|
| Myoglobin (Mb) | Mb is a muscle heteroprotein | 1st and 30th days of the trial |
| Alanine Aminotransferase (ALT) | markers of liver damage |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Older adult women
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Diego Fernández Lázaro, Professor; PhD | Contact | +34658073375 | diego.fernandez.lazaro@uva.es | |
| César Ignacio Fernández Lázaro, Professor; PhD | Contact | 658073375 | fernandezlazaro@usal.es |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Faculty of Health Sciences, University of Valladolid Soria Campus | Recruiting | Soria | 42004 | Spain |
Not provided
| ID | Term |
|---|---|
| D055948 | Sarcopenia |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D009133 | Muscular Atrophy |
| D020879 | Neuromuscular Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D013662 | Tea |
| ID | Term |
|---|---|
| D028321 | Plant Preparations |
| D001688 | Biological Products |
| D045424 | Complex Mixtures |
| D001628 | Beverages |
Not provided
Not provided
Parallel group placebo-controlled randomized clinical trial
Not provided
Not provided
Not provided
|
| Placebo | Other | Two capsules per day; Each capsule includes 100-mg maltodextrin capsules were used as a placebo to match the color and texture of the Green tea tablets to ensure blinding. |
|
| 1st and 30th days of the trial |
| Aspartate Aminotransferase (AST) | markers of liver damage | 1st and 30th days of the trial |
| Interleukin 6 (IL-6) | inflammatory marker | 1st and 30th days of the trial |
| C-reactive protein (PCR) | inflammatory marker | 1st and 30th days of the trial |
| Testosterone | hormonal marker | 1st and 30th days of the trial |
| Cortisol | hormonal marker | 1st and 30th days of the trial |
| Miostatin (GDF8) | growth factor that limits the growth of muscle tissue | 1st and 30th days of the trial |
| advanced oxidation protein products (AOPP) | amino acid oxidation marker | 1st and 30th days of the trial |
| lipid peroxidation (LPO) | lipid oxidation marker | 1st and 30th days of the trial |
| Oxygen radical absorption (ORAC) | antioxidant strength marker | 1st and 30th days of the trial |
| Total antioxidant status (TAS) | antioxidant capacity marker | 1st and 30th days of the trial |
| Total antioxidant capacity (TAC) | antioxidant capacity marker | 1st and 30th days of the trial |
| Short Physical Performance Battery (SPPB) | Test evaluates three aspects of mobility | 1st and 30th days of the trial |
| World Health Organization Quality of Life - BREF (WHOQOL-BREF) | a self-report questionnaire which assesses 4 domains of quality of life (QOL): physical health, psychological health, social relationships, and environment | 1st and 30th days of the trial |
| D001284 | Atrophy |
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012816 | Signs and Symptoms |
| D001519 | Behavior |
| D000066888 |
| Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
| D019602 | Food and Beverages |